FDA Panel Recommends Studies on Obesity Drugs Heart Risks: You can Still File a Claim for Fen Phen Adverse Events

On March 29th, 2012, an FDA Advisory Panel recommended further clinical trials for weight-loss drugs to better assess heart risks. Heart risks were associated with a popular anti-obesity drug in the 1990’s, Fen Phen. The FDA pulled Fen Phen from shelves in 1997 due to concerns about heart valve damage. According to a 2008 study published in BMC Medicine, many individuals that had taken Fen Phen in the past were found to have heart valve damage up to 7 years later. Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Fen Phen severe adverse events [http://www.attorneyone.com/fen-phen-lawsuits/ .

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Fen Phen severe adverse events threat

Fen Phen severe adverse events threat

settlement on Fen Phen as a result of many reports linking Fen Phen to serious medical problems

San Diego, CA (PRWEB) April 19, 2012

The media spotlight is often a double-edged sword. No one knows this better than people who suffer from Fen Fen severe adverse events. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

On March 29th, 2012, an FDA Advisory Panel recommended further clinical trials for weight-loss drugs to better assess heart risks. The panel mentioning the possibility of “cardiovascular risk” voted 17-6 to recommend the added heart studies. Heart risks were associated with a popular obesity drug in the 1990’s, Fen Phen. In 1997, the U.S. Food and Drug Administration ordered a recall of Fen Phen after a study published in the New England Journal of Medicine revealed that patients that took Fen Phen were 23 times more likely to develop primary pulmonary hypertension (PPH).

The Centers for Diseases Control and Prevention reported that more than one-third of US adults and almost 17% of youth were obese in 2009–2010. Obesity increases the risk of a number of health conditions including hypertension, adverse lipid concentrations, and type 2 diabetes. According to a 2008 study published in BMC Medicine, many individuals that had taken the weight-loss drug Fen Phen in the past were found to have heart valve damage up to 7 years later.

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of in case of Fen Phen severe adverse events, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat of severe adverse events from Fen Phen remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

On January 3rd 2002, American Home Products Corporation (now Wyeth) received Final Judicial Approval regarding a settlement on Fen Phen as a result of many reports linking Fen Phen to serious medical problems.

AttorneyOne informs you that if you’ve already filed a claim and received a settlement but your condition deteriorated overtime you may be eligible for further compensation.

AttorneyOne.com has further information on Fen Phen lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Fen Phen at our website. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/4/prweb9405264.htm.